Literature DB >> 21367856

Cyclic AMP-dependent protein kinase regulates the alternative splicing of tau exon 10: a mechanism involved in tau pathology of Alzheimer disease.

Jianhua Shi1, Wei Qian, Xiaomin Yin, Khalid Iqbal, Inge Grundke-Iqbal, Xiaosong Gu, Fei Ding, Cheng-Xin Gong, Fei Liu.   

Abstract

Hyperphosphorylation and deposition of tau into neurofibrillary tangles is a hallmark of Alzheimer disease (AD). Alternative splicing of tau exon 10 generates tau isoforms containing three or four microtubule binding repeats (3R-tau and 4R-tau), which are equally expressed in adult human brain. Dysregulation of exon 10 causes neurofibrillary degeneration. Here, we report that cyclic AMP-dependent protein kinase, PKA, phosphorylates splicing factor SRSF1, modulates its binding to tau pre-mRNA, and promotes tau exon 10 inclusion in cultured cells and in vivo in rat brain. PKA-Cα, but not PKA-Cβ, interacts with SRSF1 and elevates SRSF1-mediated tau exon 10 inclusion. In AD brain, the decreased level of PKA-Cα correlates with the increased level of 3R-tau. These findings suggest that a down-regulation of PKA dysregulates the alternative splicing of tau exon 10 and contributes to neurofibrillary degeneration in AD by causing an imbalance in 3R-tau and 4R-tau expression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21367856      PMCID: PMC3077661          DOI: 10.1074/jbc.M110.204453

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  61 in total

1.  A transient heterochromatic state in Xist preempts X inactivation choice without RNA stabilization.

Authors:  Bryan K Sun; Aimée M Deaton; Jeannie T Lee
Journal:  Mol Cell       Date:  2006-03-03       Impact factor: 17.970

2.  SR protein 9G8 modulates splicing of tau exon 10 via its proximal downstream intron, a clustering region for frontotemporal dementia mutations.

Authors:  Lei Gao; Junning Wang; Yingzi Wang; Athena Andreadis
Journal:  Mol Cell Neurosci       Date:  2006-11-29       Impact factor: 4.314

3.  Involvement of the catalytic subunit of protein kinase A and of HA95 in pre-mRNA splicing.

Authors:  Anne-Katrine Kvissel; Sigurd Ørstavik; Sissel Eikvar; Gaute Brede; Tore Jahnsen; Philippe Collas; Göran Akusjärvi; Bjørn Steen Skålhegg
Journal:  Exp Cell Res       Date:  2007-05-18       Impact factor: 3.905

4.  Differential incorporation of tau isoforms in Alzheimer's disease.

Authors:  Marisol Espinoza; Rohan de Silva; Dennis W Dickson; Peter Davies
Journal:  J Alzheimers Dis       Date:  2008-05       Impact factor: 4.472

5.  Human postmortem tissue: what quality markers matter?

Authors:  Ana D Stan; Subroto Ghose; Xue-Min Gao; Rosalinda C Roberts; Kelly Lewis-Amezcua; Kimmo J Hatanpaa; Carol A Tamminga
Journal:  Brain Res       Date:  2006-10-12       Impact factor: 3.252

6.  PKA modulates GSK-3beta- and cdk5-catalyzed phosphorylation of tau in site- and kinase-specific manners.

Authors:  Fei Liu; Zhihou Liang; Jianhua Shi; Dongmei Yin; Ezzat El-Akkad; Inge Grundke-Iqbal; Khalid Iqbal; Cheng-Xin Gong
Journal:  FEBS Lett       Date:  2006-10-24       Impact factor: 4.124

7.  Assessing RNA quality in postmortem human brain tissue.

Authors:  Ia Chevyreva; Richard L M Faull; Colin R Green; Louise F B Nicholson
Journal:  Exp Mol Pathol       Date:  2007-09-19       Impact factor: 3.362

8.  Tra2 beta, SF2/ASF and SRp30c modulate the function of an exonic splicing enhancer in exon 10 of tau pre-mRNA.

Authors:  Shinichi Kondo; Noriaki Yamamoto; Tomohiko Murakami; Masayo Okumura; Akila Mayeda; Kazunori Imaizumi
Journal:  Genes Cells       Date:  2004-02       Impact factor: 1.891

9.  Down-regulation of cAMP-dependent protein kinase by over-activated calpain in Alzheimer disease brain.

Authors:  Zhihou Liang; Fei Liu; Inge Grundke-Iqbal; Khalid Iqbal; Cheng-Xin Gong
Journal:  J Neurochem       Date:  2007-10-01       Impact factor: 5.372

Review 10.  Tau-mediated neurodegeneration in Alzheimer's disease and related disorders.

Authors:  Carlo Ballatore; Virginia M-Y Lee; John Q Trojanowski
Journal:  Nat Rev Neurosci       Date:  2007-09       Impact factor: 34.870

View more
  34 in total

Review 1.  Clioquinol: To harm or heal.

Authors:  Dominique R Perez; Larry A Sklar; Alexandre Chigaev
Journal:  Pharmacol Ther       Date:  2019-03-18       Impact factor: 12.310

2.  Tau promotes neurodegeneration via DRP1 mislocalization in vivo.

Authors:  Brian DuBoff; Jürgen Götz; Mel B Feany
Journal:  Neuron       Date:  2012-08-23       Impact factor: 17.173

Review 3.  Alzheimer disease therapeutics: focus on the disease and not just plaques and tangles.

Authors:  Khalid Iqbal; Fei Liu; Cheng-Xin Gong
Journal:  Biochem Pharmacol       Date:  2014-01-10       Impact factor: 5.858

Review 4.  Alternative splicing isoforms in health and disease.

Authors:  Hyoung Kyu Kim; Michael Huy Cuong Pham; Kyung Soo Ko; Byoung Doo Rhee; Jin Han
Journal:  Pflugers Arch       Date:  2018-03-13       Impact factor: 3.657

Review 5.  Cyclic nucleotide signaling changes associated with normal aging and age-related diseases of the brain.

Authors:  Michy P Kelly
Journal:  Cell Signal       Date:  2017-11-23       Impact factor: 4.315

6.  Transactive response DNA-binding protein 43 (TDP-43) regulates alternative splicing of tau exon 10: Implications for the pathogenesis of tauopathies.

Authors:  Jianlan Gu; Feng Chen; Khalid Iqbal; Cheng-Xin Gong; Xinglong Wang; Fei Liu
Journal:  J Biol Chem       Date:  2017-05-09       Impact factor: 5.157

7.  Protein kinase a-dependent phosphorylation of serine 119 in the proto-oncogenic serine/arginine-rich splicing factor 1 modulates its activity as a splicing enhancer protein.

Authors:  Anne Kristin Aksaas; Sissel Eikvar; Göran Akusjärvi; Bjørn S Skålhegg; Anne Katrine Kvissel
Journal:  Genes Cancer       Date:  2011-08

8.  Hsp70 alters tau function and aggregation in an isoform specific manner.

Authors:  Kellen Voss; Benjamin Combs; Kristina R Patterson; Lester I Binder; T Chris Gamblin
Journal:  Biochemistry       Date:  2012-01-23       Impact factor: 3.162

9.  Truncation and Activation of Dual Specificity Tyrosine Phosphorylation-regulated Kinase 1A by Calpain I: A MOLECULAR MECHANISM LINKED TO TAU PATHOLOGY IN ALZHEIMER DISEASE.

Authors:  Nana Jin; Xiaomin Yin; Jianlan Gu; Xinhua Zhang; Jianhua Shi; Wei Qian; Yuhua Ji; Maohong Cao; Xiaosong Gu; Fei Ding; Khalid Iqbal; Cheng-Xin Gong; Fei Liu
Journal:  J Biol Chem       Date:  2015-04-27       Impact factor: 5.157

10.  Cyclic AMP-dependent protein kinase enhances SC35-promoted Tau exon 10 inclusion.

Authors:  Caoyi Chen; Nana Jin; Wei Qian; Wen Liu; Xiangling Tan; Fei Ding; Xiaosong Gu; Khalid Iqbal; Cheng-Xin Gong; Ji Zuo; Fei Liu
Journal:  Mol Neurobiol       Date:  2013-09-14       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.